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background: Current guidelines of management of ST-segment elevation - myocardial infarction(STEMI) recommend that in the absence 
of hemodynamic compromise, PCI should only be performed on the culprit vessel lesion. However, available data from multiple prospective 
studies may favor complete revascularization.
methods: We performed a meta-analysis of the effect of culprit-vessel versus complete revascularization on major adverse cardiac events 
(MACE), all-cause mortality, myocardial infarction and repeat percutaneous coronary intervention (PCI). We conducted an EMBASE and 
MEDLINE search for prospective randomized, controlled trials.
results: We identified 5 prospective randomized studies with 522 patients in the culprit-vessel PCI group and 603 in the complete 
revascularization group with an average follow up duration of 16.6 months. A significant increase in MACE with culprit-vessel PCI was 
noted (figure:1a). Similarly, the rates of all-cause mortality (figure:1b), post-procedural myocardial infarctions (figure:1c) and repeat PCIs 
(figure:1d) were increased in the culprit-vessel PCI group.
 
Conclusion:  In this meta-analysis of prospective controlled studies we found decreased rates of MACE, all-cause mortality, myocardial 
infarction and repeat PCI with multivessel revascularization compared to culprit-vessel PCI.
